14/02/2019 13:15:00

Fortune Magazine names Stryker one of the 100 Best Companies to Work For in 9th consecutive year

Kalamazoo, Michigan, Feb. 14, 2019 (GLOBE NEWSWIRE) -- Kalamazoo, Michigan – February 14, 2019 – Stryker (NYSE:SYK) announced today it has been named one of Fortune’s 2019 100 Best Companies to Work For in its annual survey and evaluation of top-rated workplaces in the United States. The list recognizes companies that have exceptional workplace cultures. This is the ninth consecutive year Stryker has been named to the list, and the company was ranked #11. The full list and related stories are available at https://fortune.com/best-companies/list.

“We are one of the 100 Best Companies to Work For because of our people,” said Katy Fink, Vice President, Chief Human Resources Officer, Stryker. “Our talented employees live our mission and values every day and go above and beyond to make healthcare and our workplace better. We thank them for their passion, commitment and drive to make Stryker a special place to work.” 

Fortune partners with research firm Great Place to Work (GPTW) to create the list. GPTW scores each company on its analysis of anonymous employee responses to more than 60 questions on the Trust Index Survey. The survey represents the feedback of more than 4.3 million employees across the U.S. In addition, GPTW evaluated each companies’ programs and practices as measured through its Culture Audit© assessment.

GPTW ranks the 100 Best Companies to Work For by comparing participants’ scores against similarly sized peers to choose companies that perform the best on characteristics such as being a great place to work for all, executive team effectiveness, innovation and people-focused programs. GPTW research shows that list winners keep outperforming the stock market, beating industry rivals when it comes to talent retention and demonstrating higher levels of productivity than peers.

About Stryker

Stryker is one of the world’s leading medical technology companies and, together with its customers, is driven to make healthcare better. The company offers innovative products and services in Orthopaedics, Medical and Surgical, and Neurotechnology and Spine that help improve patient and hospital outcomes. More information is available at www.stryker.com.


For investor inquiries please contact:

Katherine A. Owen, Vice President, Strategy & Investor Relations at 269-385-2600 or katherine.owen@stryker.com

For media inquiries please contact:

Yin Becker, Vice President, Communications, Public Affairs and Corporate Marketing at 269-385-2600 or yin.becker@stryker.com

Related content
21 Aug - 
Stryker to participate in Morgan Stanley 17th Annual Gl..
12 Aug - 
Stryker announces commercial structure realignment
31 Jul - 
Stryker declares a $0.52 per share quarterly dividend

Post comment

Related debate

  • 1 week
  • 1 month
  • 1 Year
Ingen indlæg


EuroInvestor: In Focus


EuroInvestor: In Focus


EuroInvestor: In Focus

Most read news

  • 24 hours
  • 48 hours
  • 1 week
Avinger Prices $4.5 Million Underwritten Public Offering of Common Stock
MYGN Loss Alert: Hagens Berman Investigating Myriad Genetics (MYGN) For Possible Disclosure Violations
Bone Therapeutics SA to report half year 2019 results on 30 August 2019
Genmab Announces Approval of DARZALEX® (daratumumab) in Frontline Multiple Myeloma in Japan
Ambu A/S: Interim report for Q3 2018/19

Related stock quotes

Stryker Corporation 219.02 0.5% Stock price increasing

Latest news

Copyright Berlingske Media 2019  Cookie- and Privacy policy  |  Cookies  |   General terms of trade  |   Terms of use and IP rights
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
22 August 2019 11:06:02
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20190819.1 - EUROWEB1 - 2019-08-22 12:06:02 - 2019-08-22 11:06:02 - 1000 - Website: OKAY